Recent advances into the molecular mechanisms and therapeutic targeting of hepatocellular carcinoma.

Suppr

超能文献

作者信息

Chua Mei-Sze, Wang Li

出版信息

Anticancer Agents Med Chem. 2011 Jul;11(6):491-2. doi: 10.2174/187152011796011028.

DOI:10.2174/187152011796011028

PMID:21574957

Abstract

摘要

相似文献

Recent advances into the molecular mechanisms and therapeutic targeting of hepatocellular carcinoma.

Anticancer Agents Med Chem. 2011 Jul;11(6):491-2. doi: 10.2174/187152011796011028.

Hepatocellular carcinoma. Treatment potential of targeting Toll-like receptors in HCC.

Nat Rev Gastroenterol Hepatol. 2014 Sep;11(9):518. doi: 10.1038/nrgastro.2014.129. Epub 2014 Jul 22.

[Hepatocellular carcinoma].

Nihon Geka Gakkai Zasshi. 2011 Mar;112(2):122-9.

Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.

Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1301-1313. doi: 10.1080/21691401.2017.1388250. Epub 2017 Oct 12.

Multiple Approvals, Celestial Prices, Unimproved Outcomes: The Tale of Cost-Ineffective Drugs in Hepatocellular Carcinoma.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):760-762. doi: 10.6004/jnccn.2019.7317.

Latest developments in targeted therapy for hepatocellular carcinoma.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146.

Novel strategies for hepatocellular carcinoma based on MMPs science.

Anticancer Agents Med Chem. 2012 Sep;12(7):753-63. doi: 10.2174/187152012802650165.

[Current advances in molecular targeted therapy of primary hepatocellular carcinoma].

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):475-7.

Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.

Semin Oncol. 2018 Jun;45(3):116-123. doi: 10.1053/j.seminoncol.2018.03.002. Epub 2018 Mar 16.

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

Int J Oncol. 2011 Mar;38(3):721-31. doi: 10.3892/ijo.2011.902. Epub 2011 Jan 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Recent advances into the molecular mechanisms and therapeutic targeting of hepatocellular carcinoma.

Anticancer Agents Med Chem. 2011 Jul;11(6):491-2. doi: 10.2174/187152011796011028.

Hepatocellular carcinoma. Treatment potential of targeting Toll-like receptors in HCC.

Nat Rev Gastroenterol Hepatol. 2014 Sep;11(9):518. doi: 10.1038/nrgastro.2014.129. Epub 2014 Jul 22.

[Hepatocellular carcinoma].

Nihon Geka Gakkai Zasshi. 2011 Mar;112(2):122-9.

Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.

Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1301-1313. doi: 10.1080/21691401.2017.1388250. Epub 2017 Oct 12.

Multiple Approvals, Celestial Prices, Unimproved Outcomes: The Tale of Cost-Ineffective Drugs in Hepatocellular Carcinoma.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):760-762. doi: 10.6004/jnccn.2019.7317.

Latest developments in targeted therapy for hepatocellular carcinoma.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146.

Novel strategies for hepatocellular carcinoma based on MMPs science.

Anticancer Agents Med Chem. 2012 Sep;12(7):753-63. doi: 10.2174/187152012802650165.

[Current advances in molecular targeted therapy of primary hepatocellular carcinoma].

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):475-7.

Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.

Semin Oncol. 2018 Jun;45(3):116-123. doi: 10.1053/j.seminoncol.2018.03.002. Epub 2018 Mar 16.

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

Int J Oncol. 2011 Mar;38(3):721-31. doi: 10.3892/ijo.2011.902. Epub 2011 Jan 14.